v3.26.1
Business Combination (Tables)
 12 Months Ended
Mar. 31, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Schedule of Consideration Transferred
Our calculation of the consideration transferred is summarized below:
(Millions of US dollars, except share and per share data)Purchase Consideration
Consideration Transferred:
Total shares of AZEK common stock acquired143,966,912 
Cash consideration per share of AZEK common stock$26.45 
Cash for AZEK common stock3,807.9 
Cash settlement of certain stock options4.2
Cash consideration paid for common stock and stock options$3,812.1 
AZEK debt repaid as of the acquisition date437.8 
Total cash consideration paid$4,249.9 
Total shares of AZEK common stock acquired143,966,912 
Exchange ratio1.034
James Hardie Common Shares issued148,861,787 
Per share price of James Hardie common shares on July 1, 2025$26.82 
Fair value of consideration of James Hardie common shares3,992.5 
Fair value of James Hardie equity awards to be issued in exchange for certain AZEK equity awards151.1 
Total consideration transferred$8,393.5 
Schedule of Allocation of Purchase Price
The following table summarizes the allocation of the purchase price to the identifiable assets acquired and liabilities assumed, based on their estimated fair values as of the acquisition date. The purchase price allocation was based on preliminary valuations and is subject to revisions as more detailed analyses are completed and additional information about the fair value of assets acquired and liabilities assumed become available.
(Millions of US dollars)Assets Acquired and
Liabilities Assumed
Cash and cash equivalents$330.1 
Accounts and other receivables101.8 
Inventories280.0 
Prepaid expenses and other current assets19.8 
Property, plant and equipment838.2 
Intangible assets3,370.0 
Other assets - non-current135.2 
Total assets acquired$5,075.1 
Accounts payable and accrued liabilities$211.6 
Other liabilities - current74.0 
Deferred tax liabilities, net813.4 
Other liabilities - non-current158.0 
Total liabilities assumed$1,257.0 
Net assets acquired$3,818.1 
Amount of goodwill recognized$4,575.4 
Total consideration transferred$8,393.5 
Schedule of Post Acquisition and Pro Forma
AZEK results for the post acquisition period July 1, 2025 through March 31, 2026, were as follows:
Year Ended
March 31, 2026
(Millions of US dollars)(unaudited)
Net sales$1,065.0 
Net loss$(96.7)
The following unaudited supplemental pro forma financial information presents the Company’s consolidated results of operations as if the acquisition had been completed on April 1, 2024, but using the fair values of the assets acquired and liabilities assumed as of the closing date of the acquisition. This pro forma presentation does not include any impact of transaction synergies. The pro forma results are not necessarily indicative of our results of operations that actually would have been achieved had the acquisition been completed on the assumed date, nor are they necessarily indicative of future results.
Full Year Ended March 31
(Millions of US dollars)
2026
(Unaudited)
2025
(Unaudited)
Revenue$5,268.1 $5,397.8 
Net income$133.4 $315.6